======= NAT9 ======= == Gene Information == * **Official Symbol**: N/AT9 * **Official Name**: N-acetyltransferase 9 (putative) * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=26151|26151]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BTE0|Q9BTE0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NAT9&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NAT9|Open PubMed]] * **OMIM**: [[https://omim.org/entry/620913|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |Acetyltransf 1| |FR47| |transferase activity, transferring acyl groups other than amino-acyl groups| |protein acetylation| |protein acylation| |protein-containing complex| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|-1.81| |[[:results:exp421|VHL-ligand-1 20μM R07 exp421]]|-1.78| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|1.71| |[[:results:exp17|DABN 20μM R00 exp17]]|1.88| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|1.96| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|2.02| ^Gene^Correlation^ |[[:human genes:p:ppp2r3c|PPP2R3C]]|0.429| |[[:human genes:d:dpagt1|DPAGT1]]|0.425| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10270 * **Expression level (log2 read counts)**: 5.52 {{:chemogenomics:nalm6 dist.png?nolink |}}